GCTK · GLUCOTRACK INC
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
Market Cap
477.4K
52 Wk Range
$0.37 - $112.50
Previous Close
$0.60
Open
$0.59
Volume
722,829
Day Range
$0.37 - $0.62
Enterprise Value
2.791M
Cash
1.124M
Avg Qtr Burn
-3.616M
Insider Ownership
3.30%
Institutional Own.
5.20%
Qtr Updated
Jun 30th 2026
